News | November 08, 2022
SeQuent Scientific to acquire 100% stake in Tineta Pharma
The acquisition is for an enterprise value of Rs. 218 crores
The acquisition is for an enterprise value of Rs. 218 crores
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
Oncodesign Services (ODS ), with 600 clients in 33 countries and 227 employees worldwide, provides services from target identification to hit-to-lead and lead optimization through to IND filing.
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
This first joint plan on One Health aims to create a framework to integrate systems and capacity so that we can collectively better prevent, predict, detect, and respond to health threats
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
This recognition marks the third time in five years that Merck has been included on Fortune’s Change the World list.
Acquisition brings leading sickle cell disease portfolio and pipeline to Pfizer with potential to address critical needs in an underserved patient community
The agreement provides for acquisition of 13,50,000 equity shares of Rs. 100 each constituting 50% of the total equity share capital
Subscribe To Our Newsletter & Stay Updated
